TY  - GEN
AU  - Shimony,Shai
AU  - Horowitz,Netanel
AU  - Ribakovsky,Elena
AU  - Rozovski,Uri
AU  - Avigdor,Abraham
AU  - Zloto,Keren
AU  - Berger,Tamar
AU  - Avivi,Irit
AU  - Perry,Chava
AU  - Abadi,Uri
AU  - Raanani,Pia
AU  - Gafter-Gvili,Anat
AU  - Gurion,Ronit
TI  - Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study
SN  - 1099-1069
PY  - 2020///0113
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibiotics, Antineoplastic
KW  - administration & dosage
KW  - Depsipeptides
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lymphoma, T-Cell, Cutaneous
KW  - drug therapy
KW  - Lymphoma, T-Cell, Peripheral
KW  - Male
KW  - Middle Aged
KW  - Prognosis
KW  - Recurrence
KW  - Retreatment
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Observational Study
UR  - https://doi.org/10.1002/hon.2691
ER  -